3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Conditions
Colorectal Neoplasms
8
Pancreatic Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Ovarian Neoplasms
4
Neoplasms
4
Melanoma
3
Gastrointestinal Neoplasms
3
Cholangiocarcinoma
3
Breast Neoplasms
3
Urinary Bladder Neoplasms
2
Prostatic Neoplasms
2
Neoplasms by Site
2
Multiple Myeloma
2
Hematologic Neoplasms
2
Gallbladder Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Thrombocytosis
1
Thoracic Neoplasms
1
Skin Neoplasms
1
Sarcoma
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Adenocarcinoma
1
Noonan Syndrome
1
Interventions
Radiotherapy
2
Polymerase Chain Reaction
2
Nicotine
2
Gene Expression Profiling
2
Fluorodeoxyglucose F18
2
Drug Therapy
2
Counseling
2
Bupropion
2
trametinib
1
pembrolizumab
1
motexafin gadolinium
1
fluoromisonidazole
1
durvalumab
1
dabrafenib
1
cobimetinib
1
Zinc Oxide
1
Vemurafenib
1
Varenicline
1
Tobacco Use Cessation Devices
1
Taxes
1
Surgical Procedures, Operative
1
Sucralfate
1
Salts
1
Rubidium-82
1
Ritonavir
1
Radiotherapy, Intensity-Modulated
1
Quality of Life
1
Psychiatric Rehabilitation
1
Pemetrexed
1
Patient Reported Outcome Measures
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Laryngeal Neoplasms
×
cobimetinib
×
Gastrointestinal
×
Clear all
NCT05768178
2025-11-24
DETERMINE
Cancer Research UK
Phase 2/3
Recruiting
30 enrolled